|
|
|||||||||||
The British Journal of Psychiatry 152: 34-38 (1988)
© 1988 The Royal College of Psychiatrists
PB Mitchell, JA Bearn, TH Corn and SA Checkley
Maudsley Hospital, London.
The growth hormone response to clonidine was measured in ten drug-free recovered patients, seven of whom had previously been tested when endogenously depressed, and compared with the response in ten individually matched controls. In eight of the patients there was an impairment of the growth hormone response, despite clinical recovery, although the hypotensive effect of clonidine in these patients was normal. This is suggestive of a persisting abnormal alpha2-adrenoceptor function in forebrain regions after recovery from an episode of endogenous depression, and may represent a trait marker for this condition.
This article has been cited by other articles:
![]() |
B. Birmaher, R. E. Dahl, D. E. Williamson, J. M. Perel, D. A. Brent, D. A. Axelson, J. Kaufman, L. D. Dorn, S. Stull, U. Rao, et al. Growth Hormone Secretion in Children and Adolescents at High Risk for Major Depressive Disorder Arch Gen Psychiatry, September 1, 2000; 57(9): 867 - 872. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Fahlke, U. Berggren, C. Lundborg, and J. Balldin PSYCHOPATHOLOGY IN ALCOHOL WITHDRAWAL: RELATIONSHIP TO {alpha}2-ADRENOCEPTOR FUNCTION Alcohol Alcohol., September 1, 1999; 34(5): 750 - 759. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Glue, D. Nutt, and P. Glue Clonidine challenge testing of alpha-2-adrenoceptor function in man: the effects of mental illness and psychotropic medication J Psychopharmacol, January 1, 1988; 2(3-4): 119 - 137. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Psychiatric Bulletin | Advances in Psychiatric Treatment | All RCPsych Journals |